A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer
Clinical trial NCT03794596 · WITHDRAWN
Trial details
- NCT number
- NCT03794596
- Sponsor
- The Christie NHS Foundation Trust
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2021-02-28
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.